USA. FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
USA. FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene. (FDA – Federal Drug Administation, USA, 08.07.2024)
https://www.fda.gov/news-events/press-announcements/fda-approves-first-nalmefene-hydrochloride-auto-injector-reverse-opioid-overdose
- Erstellt am .
- Aufrufe: 70